T2 Biosystems, Inc.
TTOO
$0.1255
-$0.006-4.56%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 13.81% | 6.80% | 28.09% | 19.23% | 22.19% |
| Total Depreciation and Amortization | -75.10% | -55.49% | -34.41% | -17.96% | -22.85% |
| Total Amortization of Deferred Charges | -100.00% | -100.00% | -100.00% | -- | -- |
| Total Other Non-Cash Items | -13.25% | 367.42% | -83.07% | -58.98% | -65.42% |
| Change in Net Operating Assets | 147.61% | -24.50% | -985.04% | -703.58% | -1,454.21% |
| Cash from Operations | 25.40% | 15.18% | 4.58% | 4.92% | 2.18% |
| Capital Expenditure | 87.13% | 87.62% | 83.26% | 43.36% | 59.76% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Investing | 87.13% | 87.62% | -100.75% | -101.99% | -101.04% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -72.87% | -40.96% | 8.46% | 79.87% | 86.10% |
| Repurchase of Common Stock | -- | 0.00% | 92.31% | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -- | -- | -- | -- |
| Cash from Financing | -72.67% | -41.04% | 8.42% | 81.35% | 84.35% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -759.24% | -616.49% | -2,892.14% | 136.59% | 260.54% |
